🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Vaxcyte, Inc.

PCVX Healthcare
$47.19 +$0.02 (0.04%)
Market Cap: $6.81 B
Gurus Holding
6
Popularity Rank
#1374
% of Shares Held
2.00%
Net Activity (Q1 2026)
+$75.28 M

Guru Ownership Trend

Guru Analysis for Vaxcyte, Inc. (PCVX)

Vaxcyte, Inc. (PCVX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $136.44 M.

Top institutional holders include Lee Ainslie and Seth Klarman.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $75.28 M net inflow during the quarter.

Recent activity highlights Steven Cohen who increased their stake by 283.9%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 16.1%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$75.89 M
Total Buy Value
New Buys 2
Additions 3
-$608,818.52
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
1
Net Buyers
5

FAQs for Vaxcyte, Inc. (PCVX)

Major holders include Lee Ainslie ($80.06 M), Seth Klarman ($46.49 M), Steven Cohen ($36.05 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 2.89 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $75.28 M, with 5 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited PCVX. The total reported sell value was $608,818.52.

Yes, 2 managers opened new positions in PCVX, and 3 increased their existing holdings. The total reported buy value was $75.89 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.92% Add 1.7% 1,377,738 $80.06 M Q1 2026
0.91% New Buy 800,000 $46.49 M Q1 2026
0.05% Add 283.9% 620,401 $36.05 M Q1 2026
0.00% Reduce -16.1% 54,734 $3.18 M Q1 2026
0.00% Add 72.5% 25,458 $1.48 M Q1 2026
0.00% New Buy 12,903 $749,793 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form